INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 216 filers reported holding INARI MED INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,150,964 | +2.3% | 904,449 | -9.0% | 0.01% | 0.0% |
| Q2 2023 | $57,802,265 | -16.6% | 994,191 | -11.4% | 0.01% | -14.3% |
| Q1 2023 | $69,287,036 | -14.4% | 1,122,239 | -11.9% | 0.01% | -22.2% |
| Q4 2022 | $80,951,922 | +338.3% | 1,273,630 | +400.9% | 0.01% | +200.0% |
| Q3 2022 | $18,469,000 | +1.5% | 254,252 | -5.0% | 0.00% | +50.0% |
| Q2 2022 | $18,196,000 | +7.2% | 267,617 | +42.9% | 0.00% | 0.0% |
| Q1 2022 | $16,980,000 | +56.9% | 187,329 | +58.0% | 0.00% | +100.0% |
| Q4 2021 | $10,819,000 | -24.3% | 118,548 | -32.8% | 0.00% | -50.0% |
| Q3 2021 | $14,300,000 | -13.9% | 176,320 | -1.0% | 0.00% | 0.0% |
| Q2 2021 | $16,617,000 | +62.9% | 178,144 | +86.8% | 0.00% | +100.0% |
| Q1 2021 | $10,202,000 | -68.9% | 95,342 | -74.6% | 0.00% | -80.0% |
| Q4 2020 | $32,762,000 | +1413.3% | 375,319 | +1096.5% | 0.01% | – |
| Q3 2020 | $2,165,000 | +469.7% | 31,367 | +300.5% | 0.00% | – |
| Q2 2020 | $380,000 | – | 7,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |